Measurable residual disease by multiparametric flow cytometry in acute lymphoblastic leukemia

3 Views

08/04/23

Webinar presenter, Brent L. Wood, MD, PhD, Director of Hematopathology, Professor, Pathology and Laboratory Medicine, Children’s Hospital Los Angeles, University of Southern California, discusses an overview of multiparametric flow cytometry for MRD testing in B-ALL, including an in-depth review of the methodology and special considerations, data analysis, reporting, and clinical decision-making based on MRD results, patient cases that demonstrate the use of multiparametric flow cytometry for MRD testing in B-ALL. Moderated by: Bob McGonnagle, Publisher, CAP TODAY. This on-demand webinar originally broadcast July 29, 2021. (USA-103-81007)